Speakers

Institute of Chemistry, Biology of Membranes and Nano-objects, University of Bordeaux, France

c.tokarski@cbmn.u-bordeaux.fr

https://orcid.org/0000-0001-7296-3330

Caroline Tokarski is Professor of analytical chemistry at the University of Bordeaux and external Professor at the National Academy of Pharmacy. She is Director of the Proteome Platform of Bordeaux and co-Director of the CNRS international laboratory ARCHE with the Metropolitan Museum of Art, New York.

Her research focuses on methodological developments for analysis of biological macromolecules of native or transformed organic materials using high resolution mass spectrometry. A major part of her activities investigates trace level analysis and study of complex matrices. She introduced proteomics to the field of Cultural Heritage, allowing the accurate structural characterization of ancient proteins, and championed a robust platform of omics approaches (proteins, lipids, polysaccharides), within the EU and international infrastructures for Cultural Heritage. With her group, her current work focuses on structural macromolecular assemblies and molecular networks in ancient samples using minimally invasive workflows. 

Caroline Tokarski is highly involved in European and International research and training networks for cultural heritage, and she is involved in the deployment and implementation of omics mass spectrometry-based workflows inside international museums and associated laboratories. 

Centre for Blood Research, University of British Columbia, Canada

chris.overall@ubc.ca

https://orcid.org/0000-0001-5844-2731

Chris Overall is a Tier 1 Canada Research Chair in Protease Proteomics and an Honorary Professor Albert-Ludwigs Universität Freiburg, Germany. He was inducted as a fellow into the Royal Society of Canada in 2018 and is Chair of the HUPO C-HPP. After completing his Master’s at the University of Adelaide, South Australia he did his Ph.D. at the University of Toronto, Canada. Chris is best known for his development of proteomic methodology for discovering protein N and C-termini and protease substrates in vivo, thereby establishing the field of terminomics or degradomics. Degradomics has revealed a new layer of complexity in the hierarchy of cell and immune signalling regulation, revolutionizing our understanding of protease function and drug targeting. These insights led to the development of a new class of molecular correctors to treat MALT-1 deficiency and NF-kB activation in immunodeficiency. In the pandemic, Chris pivoted to the investigation of SARS-CoV-2 proteases, revealing their drastic impact on cleaving hundreds of host cell proteins promoting the cellular takeover by the virus. His advances in proteomics have been recognized by the CNPN Tony Pawson Award (2014) and the 2018 HUPO Discovery Award. He is an Associate Editor of the Journal of Proteome Research.

Dpt. Experimental Pathology. IIBB-CSIC-IDIBAPS, Barcelona, Spain

daniel.closa@iibb.csic.es

https://orcid.org/0000-0003-3797-3095

Daniel Closa has a PhD in Biology and has been researching inflammatory diseases at the CSIC’s Barcelona Institute for Biomedical Research for over thirty years. He is the author of more than 100 articles published in scientific journals, but in addition to his research work he also maintains activity in the field of scientific dissemination. He is the author of works of fiction and science dissemination, such as "100 Myths of Science," "100 Questions About Cancer," and "Anthropocene: The End of a World." He has also collaborated on various radio and television programs.

PRISM Laboratory, University of Lille, France

isabelle.fournier@univ-lille.fr

https://orcid.org/0000-0003-1096-5044

Prof. Fournier is Distinguished Professor at University of Lille and she helds a position as co-director of the PRISM Inserm U1192 Lab. She is a bioanalytical chemist specialized in clinical mass spectrometry and proteomics. She started research working on fundamental of MALDI during her PhD at University Pierre & Marie Curie in Paris first and then, as a postdoctoral fellow within the group of Prof. Michael Karas in Frankfurt. In 2002, she established her own group at University of Lille where she started developing MALDI MS Imaging. She contributed to the field with several developments including strategies for imaging of FFPE tissues and proteins, and the development of tagged-probes for specific imaging of mRNA and antigens. In 2009, she was hired as Full Professor and awarded a Junior position at Institut Universitaire de France. Since 2012, she got interested by the development of Spatially-Resolved Proteomics in combination to MALDI MSI for applications in oncology. Over the past 5 years, she also worked on the development of in vivo MS for guided surgery and intraoperative analysis. She has authored 181 publications (h-index 46, 7070 citations) and presented 141 oral communications including 84 on invitation. She confounded the Imabiotech Company which provides services in MALDI MSI. She was recently distinguished by the international distinguish award from MSACL and was awarded a senior position at Institut Universitaire de France. 

CEA - Commissariat à l’énergie atomique et aux énergies alternatives, France

jean.armengaud@cea.fr

https://orcid.org/0000-0003-1589-445X

Jean Armengaud is Chief Deputy of the “Laboratory of Innovative Technologies for Detection and Diagnostics” located near Avignon in France. He is also Director of the ProGénoMIX platform, specialized in proteogenomics and metaproteomics. His goal is to contribute to a better understanding of the functioning of complex biological systems and exploit this knowledge for medical and environmental purposes. He is expert in proteogenomics, the alliance of genomics and proteomics for the characterization of non-model organisms, in metaproteomics, as well as in mass spectrometry for the identification and characterization of pathogens. He is also active in the field of protein biomarkers for medical and environmental purposes, and develops new methodologies for the study of microbiota. He received his Ph.D. in biochemistry in 1994 at the University of Grenoble. He has published 237 peer-reviewed papers. Recently, his group worked at developing methodologies to detect SARS-CoV-2 virus, a crucial topic.

University of Copenhagen, Denmark

jesper.olsen@cpr.ku.dk

https://orcid.org/0000-0002-4747-4938

Jesper Olsen studied analytical chemistry at University of Southern Denmark in the laboratory of Roman Zubarev. After this, he worked two years at MDS Proteomics as staff scientist before joining the laboratory of Matthias Mann as PhD student. He spent 4 years as a post-doctoral fellow at the Max Planck Institute for Biochemistry in Munich. In 2009, Jesper was recruited to head a group at the newly established Novo Nordisk Foundation Center for Protein Research (CPR) at University of Copenhagen (UCPH). In 2012, he was promoted to vice director of CPR and in 2014 full professor at UCPH.

 

Jesper made seminal contributions to the field of proteomics and high-resolution mass spectrometry, and pioneering quantitative phosphoproteomics technology and its application to study cell signaling networks to answer outstanding questions in biology. His group is developing proteomics technology and their work on offline peptide chromatographic fractionation in combination with fast online LC-MS/MS has enabled comprehensive analysis of human proteomes. Most recently, his group has worked on the combination of FAIMS and DIA on the Orbitrap Exploris 480 MS for high-throughput analysis of human proteomes and spatial-proteomics revealing phospho-signaling dynamics at subcellular resolution. 

Institut Pasteur, Paris, France

julia.chamot-rooke@pasteur.fr

https://orcid.org/0000-0002-9427-543X

Julia Chamot-Rooke is an Analytical Chemist by training and Senior Scientist at CNRS. She is the head of the Mass Spectrometry for Biology (MSBio) Laboratory at the Institut Pasteur, Paris since 2012. She was previously group leader at the Department of Chemistry of the Ecole Polytechnique. At the Institut Pasteur, her lab proposes research and service in proteomics. Her research focuses on the development of innovative analytical pipelines in top-down proteomics and in structural proteomics, mostly for applications in the field of infectious diseases. Julia Chamot-Rooke is a Past President of the French Society for Mass Spectrometry. She is also a founding member and executive board member of the International Consortium for Top-Down Proteomics (CTDP). In 2019, she co-organized with the CTDP the first European Top-Down Proteomics Symposium at the Institut Pasteur. Julia Chamot-Rooke is the coordinator of several multidisciplinary projects in life sciences. Her lab is also the French partner of the European Research Infrastructure in Proteomics (EPIC-XS). Her work already led to 113 publications and more than 50 invitations into national and international workshops and conferences. 

Max Planck Institute of Biochemistry, Germany

cox@biochem.mpg.de

https://orcid.org/0000-0001-8597-205X

Juergen Cox is a research group leader at the Max Planck Institute for Biochemistry

in Munich Germany, where he heads the Lab for Computational Systems Biochemistry.

He received his PhD in physics at the Massachusetts Institute of Technology and has

since developed MaxQuant, a quantitative proteomics software package designed for analyzing

large mass spectrometric data sets. Dr. Cox is the author of numerous peer reviewed

publications in the field of data analysis in mass spectrometry and quantitative proteomics.

Institute for Research in Biomedicine (IRB Barcelona)

marina.gay@irbbarcelona.org

https://orcid.org/0000-0002-8827-7092

Marina Gay received her PhD degree in Chemistry (2004) from the University of Barcelona (UB). After, she was a postdoc at the LP-CISIC/UAB in the group of Joaquin Abian and Montserrat Carrascal, where she focused her activity on the characterization of the human T lymphocyte phosphoproteome during its activation and on the biomarker discovery in cholestasis. Since 2012, she has been working in the Mass Spectrometry and Proteomics Core Facility at IRB Barcelona with Marta Vilaseca. There she gained knowledge in structural proteomics and top-down proteomics. Her main interest is the study of proteoforms and their direct connection with phenotypes and diseases, focused on the study of protamines and their role in male infertility. She is also interested in the data analysis of all proteomics fields, developing and establishing new pipelines for quantitative proteomics and the subsequent statistical analysis. She has been involved in the organization of several national and international conferences related to mass spectrometry and proteomics. She has been a member of ProteoRed since its creation in 2005 and since 2020, she is a member of the Board of Directors of the Proteomics Spanish Society (SEProt). 

Institute of Molecular Systems Biology (IMSB), ETH Zurich, Suisse

Michal.Bassani@chuv.ch

https://orcid.org/0000-0002-1934-954X

Michal Bassani-Sternberg received her PhD degree in Biology (2010) from the Technion - Israel Institute of Technology. From 2011 to 2015 she was a post-doctoral researcher at the Proteomics and Signal Transduction Department, headed by Prof. Matthias Mann at the Max Planck Institute of Biochemistry. Currently she is assistant professor at the University of Lausanne and her lab is affiliated to the Center of Experimental Therapeutics at the Oncology Department at the University Hospital of Lausanne (CHUV) and to the Ludwig Institute for Cancer Research, Lausanne branch. Her group develops and implements advanced experimental and computational mass-spectrometry based antigen discovery workflows to support development of personalized cancer immunotherapy and early phase experimental cancer vaccines.

Institute of Molecular Systems Biology (IMSB), ETH Zurich, Suisse

pbeltrao@ebi.ac.uk

https://orcid.org/0000-0002-2724-7703

Pedro Beltrao has a Biochemistry degree from University of Coimbra (2002) and a PhD in Biology from the University of Aveiro for research conducted at EMBL-Heidelberg under the supervision of Luis Serrano (2007). He did his postdoctoral research at the University of California San Francisco under the supervision of Prof. Nevan Krogan (2008-2012). He was a group leader at EMBL-EBI from 2013 to 2021 and he is now an Associate Professor at the Department of Biology, ETH Zurich from Jan 2022